Senior Principal Scientist, Clinical Pharmacology Genentech, Inc. South San Francisco, California
Join Katie Maass, Ph.D., NBC Scientific Program Committee Chair and several authors in Forum #1 in the Solution Center for a conversation about posters she is especially excited about relating to Track 2 - Novel Strategies to Advance Biotherapeutic Development.
T1530-02-07 Integrated HypoSkin® Model and PBPK Modeling as a Bioavailability Predicting Tool for Subcutaneous Delivery of Protein Therapeutics, Hongzhi Wang, Genentech, Inc.
W1530-02-06 Age-Dependent Reduction in Hepatic Vector Genome Loss in Juvenile OTCspf-ash Mice Following a Single Dose of DTX301 and Partial Compensation Achieved with a Higher Dose, Tim Chiu, Ultragenyx Pharmaceuticals
T1530-02-06 Development of an Electrochemiluminescent Assay for the Detection of Anti-PEG IgE Antibodies in Human Serum, J. Javier Aguilera, Moderna Therapeutics
T1530-02-10 Development of a Generic, Automated, Microfluidic Human IgG-FcRn Affinity Assay In-Solution for Use in Antibody Engineering, Jasmine Singh, MS, Gyros Protein Technologies
W1230-02-11 Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics and Vaccines Using In Silico and In Vitro Methods, Mitchell McAllister, EpiVax, Inc.
